International Market Access Upper Degree
Gain key insights into the market access governing global healthcare and explore how effective policy can be used to address contemporary challenges.
REGISTRATION FOR NEXT MODULE COMING SOON
Who can benefit from this market access course?
Market Access Professionals
Individuals already established in the field of market access who seek to further refine their understanding and solidify their knowledge base, enhancing their career prospects in the pharmaceutical and life sciences industries.
Students
Are you studying Medicine, Pharmacy, or Life Sciences and looking to build a successful career in Market Access? This course is perfect for those asking, “How do I become a Market Access specialist?” and aiming to establish themselves in this dynamic field. It’s an excellent resource for those exploring career opportunities after completing studies in Pharmacy and Life Sciences.
Industry Professionals Transitioning to Market Access
Professionals from other sectors of the pharmaceutical, life sciences, or consulting industries looking to transition into Market Access roles.
job offers in the sector require the knowledge contained in the course
job offers in the sector require the knowledge contained in the course
job offers in the sector require the knowledge contained in the course
Benefits for you?
- Set up a successful market access strategy.
- Develop, validate and execute a market access plan.
- Build value story to optimize market access.
- Understand strengths and pitfalls of available evidence.
- Design pricing research.
- Anticipate the future paradigm changes in market access.
- Acquire the market access mindset.
interactive quizzes
to test knowledge
and comprehension
workshop exercises and case studies for hands-on practice,
engaging videos featuring expert insights
supplementary readings and resources for deeper dives
Benefits for your organization?
-
Enhanced Expertise:
Accelerate your executives' understanding of evolving market access trends and challenges to develop and implement your strategic planning of each stage of a drug’s life cycle. -
Stronger Product Positioning:
Develop more effective market entry strategies to ensure product success across international markets. -
Increased Competitiveness:
Keep informed with the latest Market Access trends, tools and regulations to stay one step ahead of the competition. -
Improved Stakeholder Relations:
Gain the ability to communicate and negotiate with regulators and decision-makers to achieve business goals faster. - Networking opportunities: Meet and exchange your experiences with the most prominent market access specialists. Join the market access community and keep in touch with lecturers, students and others involved in the market access industry on a daily basis
Ours instructors
Lylia Chachoua
Senior Consultant PRMA in Clever-Access
Hervé Lamarque
VP at Incyte Head of EU Access, Pricing, HEOR and Business development
Isaac Odeyemi
Head of Outcomes Research
Wael Belgaied
Pricing & Market Access Consultant in Inov Intell
Emilie Clay
Co-Founder of Clever-Access
Vivian Chen
Professor and Senior Researcher at Tsinghua University-Hospital Management Institute
Philippe Larame
Head of Payer Engagement, Capabilities & Innovation at Ipsen Headquarters
Ulf Person
Senior Advisor at IHE - The Swedish Institute for Health Economics
Keith Tolley
Director at Tolley Health Economics
Ataru Igarashi
Associate Professor at Yokohama City University School of Medicine
James Chambers
associate professor at Tufts Medical Center Institute for Clinical Research and Health Policy Studies
Dávid Danko
managing partner at Ideas & Solutions (I&S)
Course description
Market Access is a complex process often referred to as the fourth hurdle in drug development, and it has become an inescapable reality in today’s pharmaceutical landscape. As the primary driver of the global income of new products and drugs, Market Access strategies are crucial for any company aiming to succeed in the competitive pharmaceutical and medical device sectors. No company can expect to thrive without designing a comprehensive market access strategy early in the development process and executing it effectively.
Becoming a Market Access specialist requires not only deep knowledge but also advanced professional capabilities. The IMAUD program offers a robust market access course that is situated at the crossroads of multiple disciplines, providing the essential skills and insights needed to master this field. If you’re wondering how to become a market access expert, this program is designed to equip you with the expertise and practical experience to excel in this critical area.
Programme content
- Market Access Landscape and Policy
- Market Access Activities in Early Preparation Phase I/II
- Market Access Activities in Phase III/Pre-Launch
- Market Access Activities in Launch/Post-Launch/LCM
- Market Access for Vaccines, Medical Devices, and Diagnostics
Employees of these companies participated in the course.
What do you need to know?
How many modules are included in the course?
The program consists of 5 mandatory modules . The 5 modules can be done separately i.e., not necessarily in only one year, and not in any specific order.
Practical or theoretical?
Practical applications for each main topic.
Multiple examples from the public domain and lecturers experience.
The full development of a Market Access Plan including strategy, gap analysis, activity prioritization.
Each module will contain case study, workshop, quizzes and live panel discussion session.
Where can I find the exact outline of the course modules?
You can find it here
Do I have to submit the thesis at the end?
To successfully complete the Imaud course, a project is required: a research work (thesis), which must be delivered by October, the same calendar year in which the last module 5 of the course was held. The main objective of the thesis is to demonstrate your ability to analyze and think strategically in relation to any market access question.
The thesis should be in English and should not exceed 50 pages or a maximum of 50 PowerPoint slides.
Your thesis can cover one or several of the following topics:
- Literature review conducted according to state of art
- Review of HTA or pricing decisions
- Landscape analysis
- Case Study
- Health economics project
- Pharmaco-epidemiology project
- Pricing research
- Market Access Strategy
- Market Access perspectives and drug development, HEOR applied to market access
There are no minimum slides or pages. What count is value not quantity.
It could eventually be done jointly with up to 3 candidates maximum.
For sensitive case studies, we exert full confidentiality, ensuring that the thesis is not available to any third party and stored safely. A confidentiality agreement will be signed, and the thesis returned to the candidate. However, when possible, we prefer to avoid confidential topics.
On successful completion of your course and positive evaluation of your research work, you will receive a diploma delivered by MAS. We do not deliver grade but positive or negative decision
What is the exact date of the course?
The exact dates of the modules in 2024 are:
Module 1: 14.10.2024 – 18.10.2024
Module 2: 9.12.2024 – 13.12.2024
Module 3: 10.02.2025 – 14.02.2025
Module 4: 07.04.2025 – 11.04.2025
Module 5: 23.06.2025 – 27.06.2025
How can I apply?
You can purchase through our website the entire course or access to a single module.
Or you can send the CV and a cover letter to
administration@marketaccesssociety.org
How much does the course cost?
€8,000 per entire course
€1,600 per module
*) The attendance to IMAUD courses is compulsory. Tuitions and scholarship fees will not be refunded in case of absence.
Acquire the IMAUD
